News
The Sectors Quietly Winning While Investors Focus on Tech
Most investors remain hyperfocused on technology stocks and artificial intelligence (AI) stocks in particular -- understandably so. AI still promises to revolutionize the world in ways we've yet to
Hedge Fund Wagers $36 Million on Biotech Denali After First FDA Approval
On May 15, 2026, ADAR1 Capital Management disclosed in an SEC filing that it bought 1,819,339 Denali Therapeutics shares, an estimated $36.20 million trade based on quarterly average pricing.
Should You Lock In Gains Before Summer or Let Your Winners Ride?
Over the past 12 months, the S&P 500 and Nasdaq have risen about 25% and 35%, respectively. Both indexes are hovering near record highs and trading at historically high valuations, even amid
Nvidia Stock Investors Just Got (More) Fantastic News from Wall Street
Nvidia (NASDAQ: NVDA) stock has rewarded shareholders since early 2023, racking up gains of 1,420% -- but it hasn't all been smooth sailing. The artificial intelligence (AI) chipmaker has tumbled
AI Isn't Just GPUs and CPUs: Here's the AI Trade No One Is Talking About
Much of the attention surrounding the AI infrastructure buildout is focused on GPUs and CPUs, and for good reason. But meanwhile, Micron (NASDAQ: MU), SanDisk (NASDAQ: SNDK), and other manufacturers
Why Poet Technologies Is Plummeting Today
Poet Technologies (NASDAQ: POET) stock is moving lower in Monday's trading. The company's share price was down 12.6% as of 2:05 p.m. ET. The S&P 500 was down 0.3% at the same point in the daily
This Nvidia-Backed Company Just Entered an $800 Billion Agentic AI Market. Does This Make the $14 Stock a No-Brainer Buy?
In the world of telecommunications, Nokia (NYSE: NOK) is undergoing a quiet, albeit noteworthy, transformation. The company that was once synonymous with mobile phones is pivoting beyond its more
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
On May 15, 2026, ADAR1 Capital Management disclosed a new position in Beam Therapeutics (NASDAQ:BEAM), acquiring 1,446,375 shares in an estimated $40.13 million trade based on quarterly average
NuScale Power Just Reported Earnings. Here's Why I'd Buy After the Numbers Dropped.
NuScale Power (NYSE: SMR) has huge growth potential. The nuclear company is chasing a multi-trillion-dollar opportunity that should persist for decades to come.
That opportunity is made possible
3 High-Yielding Dividend Stocks Trading at Dirt Cheap Valuations
Want to invest in a stock that's incredibly cheap, that offers a high yield, and whose payout is safe? I've got a list of three such stocks that meet that criteria, and that could make for
Hedge Fund Drops $37 Million on Rare Disease Biotech Crinetics. Is It a Buy?
On May 15, 2026, ADAR1 Capital Management disclosed a buy of 829,963 shares of Crinetics Pharmaceuticals (NASDAQ:CRNX), an estimated $37.07 million trade based on quarterly average pricing.
This Fintech Stock Fell 17% Last Year. One Fund Just Fully Exited a $4 Million Stake
13D Management sold out its entire position in Bill.com (NYSE:BILL) during the first quarter, according to a May 15, 2026, SEC filing. The estimated transaction value was $4.03 million, based on
This Beaten-Down Tech Stock Presents a Generational Buying Opportunity
"Magnificent Seven" stocks have a long history of beating the S&P 500, but Meta Platforms (NASDAQ: META), one of the seven, has been a recent laggard. It's down by 4% over the past year, while the
Why This Fund Made a $5 Million Bet on Acadia Healthcare Despite a Flat Stock
On May 15, 2026, 13D Management disclosed a new position in Acadia Healthcare (NASDAQ:ACHC), acquiring 294,000 shares in a trade estimated at $5.32 million based on quarterly average pricing.
This Wealth Manager Just Bet $5.8 Million on BlackRock's Active Country Rotation ETF
On May 15, 2026, Barnes Wealth Management Group disclosed a new position in BlackRock ETF Trust - iShares International Country Rotation Active ETF (NASDAQ:CORO), acquiring 180,394 shares for an
If You Do This With Your Inherited IRA, You're Probably Costing Yourself Big Time
You probably have a lot of ideas about what you'd like to do with your inherited individual retirement account (IRA), and you're free to do whatever you want with the money. But there are still a
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing
On May 15, 2026, Octagon Capital Advisors disclosed a new stake in Xenon Pharmaceuticals (NASDAQ:XENE), acquiring 490,000 shares in a transaction estimated at $22.58 million based on quarterly
3 Stocks That Have Turned $15,000 Into $4 Million in 20 Years
A buy-and-hold strategy can generate life-changing returns for investors, and the stocks listed below are prime examples of that. While there can be risks with investing in companies in their early
Here's Why Ryanair Stock Flew Higher Today
Shares in Ireland's ultra-low-cost carrier Ryanair Holdings (NASDAQ: RYAAY) popped higher by 8.4% in early morning trading as the market digested an excellent set of fourth-quarter earnings. The
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish
Octagon Capital Advisors cut its stake in Dianthus Therapeutics (NASDAQ:DNTH) by 470,000 shares, an estimated $27.22 million trade based on quarterly average pricing, according to a May 15, 2026 SEC
Prediction: This Beaten-Down Tech Stock Will Outperform the S&P 500 by 2027
Some stock drops present meaningful long-term buying opportunities for patient investors who can ignore the noise. Reddit (NYSE: RDDT) looks like one of those growth stocks. It's down by more than
Is AI Infrastructure Spending Heading for an Even Bigger Boom? What ARM, Shift4, SpaceX, and Anthropic Just Told Us
In this video, I will cover the biggest market stories of last week, including ARM (NASDAQ: ARM) and Shift4 earnings reactions, SpaceX's major investment in Terafab, and Anthropic's massive compute
The Best 3 Consumer Staples Stocks to Buy and Hold for Decades
While I may be taking a few liberties in calling the three stocks in this article consumer "staples" companies, I think each business offers a lot of the defensive traits that make the sector
3 Beaten-Down Stocks That Could Take Off if Interest Rates Come Down This Year
There's a new Fed chair with Kevin Warsh taking over, and there's plenty of debate about whether interest rates might come down this year. While inflation has been a concern of late, the president
Landmark Investment Partners Reduces Douglas Emmett Stake, According to Recent SEC Filing
According to a SEC filing dated May 15, 2026, Landmark Investment Partners reduced its reported common-stock position in Douglas Emmett (NYSE:DEI)during the first quarter. The fund’s position in the